Filed under: Earnings reports, Cisco Systems (CSCO), Time Warner (TWX), Motorola (MOT), Estee Lauder (EL), NYSE Euronext (NYX), BP p.l.c. ADS (BP), Anadarko Petroleum (APC) Here are some highlights from this past week's earnings coverage from BloggingStocks: Anadarko Petroleum Corp. (NYSE: APC) repo...

Biotech, acquisitions, diabetes Luke Timmerman wrote: Carl Icahn has sized up one of San Diego’s biggest biotech companies, Amylin Pharmaceuticals, in the crosshairs. The famed billionaire investor said today he has bought up an 8 percent stake in the company, and that he intends to nominate a...

Biotech, acquisitions, Autoimmune Luke Timmerman wrote: Pfizer rocked the business world yesterday with its $68 billion bid to acquire Madison, NJ-based Wyeth (NYSE: WYE), and the ripple effect was felt here in the Northwest. Nobody in town has a bigger stake in this deal than Seattle-based Trubion ...

Filed under: Pfizer (PFE), Newsletters, Johnson and Johnson (JNJ), Bristol-Myers Squibb (BMY), Stocks to Buy, Best Stocks for 2009 Health care has long been considered a recession-resistant business. Given the current economic challenges, it's little surprise that in our survey of favorite stocks fo...

Biotech, Cash, Life Sciences Luke Timmerman wrote: Boston is the biggest center of life sciences in the Xconomy network, and by our analysis, the Bay State’s biotech sector is also the best equipped to survive the economic crisis. I reached this conclusion by combing through public company fil...

Biotech, Multiple Sclerosis, Drugs Luke Timmerman wrote: If Genzyme gets its way, it will be eating Biogen Idec’s lunch in a few more years. The two Cambridge, MA-based companies, the largest independent biotechs in the state, could be duking it out with competing multiple sclerosis treatments...

Look out Jerry Yang, Carl Icahn now has one fewer distraction as he prepares to propose his slate of dissident board nominees at Yahoo’s Aug. 1 shareholder meeting. At its own shareholder meeting yesterday, Biogen (BIIB) investors voted to support management’s preferred board candidates and ...

Biotech, Life Sciences, events Luke Timmerman wrote: Washington state doesn’t do much Texas-style boasting, and the state’s economic development promoters have never tossed around big bucks to crow about the biotechnology cluster here. Case in point: how many of you know that the world&#...